Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma

Published

August 6, 2021

Doi

https://doi.org/10.3390/cancers13163978

References

Rausch, Magdalena, Adriano Rutz, Pierre-Marie Allard, Céline Delucinge-Vivier, Mylène Docquier, Olivier Dormond, Paul J. Dyson, Jean-Luc Wolfender, and Patrycja Nowak-Sliwinska. 2021. “Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma.” Cancers 13 (16): 3978. https://doi.org/10.3390/cancers13163978.